Category: Patient Education

26

Mar2019
This month Enzymotec, the makers of Vayarin, quietly announced on their website that they would no longer sell its product in the U.S. This leaves patients who have been taking it in a quandary without support. While the company’s announcement cites “a lack of alignment with our business strategy” as an explanation, no one ... Read More
March 26, 2019David W. Goodman, MD

07

Mar2019
Parenting an ADHD child is challenging. Yet, this challenge is heightened when one or both of the parents have ADHD. While consistent behavioral routines are advocated in ADHD households, untreated ADHD parents will have great difficulty executing consistent oversight of their children. from Today.com reviewed a video of a family whose ... Read More

07

Mar2019
CVS CAREMARK CRITERIA Starting January 1, 2018, these patients may not be able to fill their current medication at the pharmacy, based on the plan's coverage changes. Please visit caremark.com/highvalueplan to review the coverage details of this pharmacy benefit plan.   PA                                    = Prior Authorization                                    There must be a satisfied PA on ... Read More

07

Mar2019
UnitedHealthCare/Optum were cited by the court to have created internally generated algorithms for mental health care that fell short of acceptable standards for professional psychiatric associations. Your frustration from inadequate coverage now has a reason. Read the following details from the Psychiatric News March 7, 2019. UBH Found to Have Wrongfully ... Read More

02

Mar2019
"What can I expect as an adult from my ADHD treatment in the first 6 months?" I have been invited to speak online LIVE for the Children and Adults with ADHD Association Webinar Series "Ask the Expert". I will discuss the benefits of ADHD treatment as they unfold over the first ... Read More

05

Mar2018
Technology is not always a cooperative servant. My ADDitude Magazine webinar scheduled on Febuary 27, 2018 was interrupted by a technical problem after 10 minutes. No one was more upset about this than I. However, good news. the webinar has been rescheduled for May 1 Tuesday 1pm for 1 hour. ... Read More

03

Mar2018
This is Part 2 to a previous blog: This brings us to the next objection insurance companies will raise – the issue of safety. In citing safety as a reason for the denial of daily stimulant doses that exceed FDA daily max allowances, they deliberately and knowingly misrepresent the meaning of ... Read More

18

Feb2018
My patients have been complaining for years about getting there prescribed ADHD medications approved by their insurance companies. With each passing year this becomes increasingly more difficult. Since January 1, 2018, with insurance companies making changes to policies and formularies (tier system that determines copayment amounts for medication), patients have ... Read More
February 18, 2018David W. Goodman, MD

10

Feb2018
U.S. News and World Report interviewed me  in December 2017 about recent research publication (Language of ADHD in Adults on Social Media, Dec 2017) comparing the use of social media between ADHD and non-ADHD people. The authors specifically looked an the vocabulary between each group and discovered, not surprisingly, that ADHD ... Read More
February 10, 2018David W. Goodman, MD

03

Jun2017
National Public Radio recently posted my interview (click on "Heard on Morning Editon") from April 2017 about a research publication reviewing a revised adult ADHD screener developed in coordination with the World Health Organization. What the journalist didn't know at the time that I will share with you is that I ... Read More